Publications by authors named "T Chantler"
Background: Despite repeated calls to action and considerable attention, childhood vaccination uptake has declined for a thirteenth consecutive year in the United Kingdom (UK). Increasingly, stakeholders are advocating for research which goes beyond vaccine hesitancy and explores service accessibility in greater depth. This scoping review aims to identify and critically assess how accessibility is being conceptualised and investigated with a view to informing future research.
View Article and Find Full Text PDFArticle Synopsis
- Typhoid conjugate vaccines are recommended for inclusion in India's Universal Immunisation Programme to combat typhoid fever, and this study aims to gather evidence to support their implementation.
- A literature review was conducted to evaluate evidence regarding the disease's burden, the vaccine's benefits and harms, its cost-effectiveness, and the feasibility of implementing it in India.
- The study found significant evidence gaps in areas like budget impact, vaccine demand, and provider acceptability, suggesting a need for targeted research to aid decision-making for the vaccine's rollout.
Article Synopsis
- The project aimed to create films that help parents make decisions about the HPV vaccine for their teenagers by using evidence and feedback from the community.
- They worked with parents and professionals to understand what information is important, such as the benefits and safety of the vaccine, and made sure the films were in different languages.
- Parents liked the films and suggested using social media and schools to share information about the HPV vaccine before asking for consent.
Social science research on polio has been centred in the global south, where countries that remain endemic or vulnerable to outbreaks are located. However, closely-related strains of poliovirus were detected in the sewage systems of several New York State counties and London boroughs in 2022. These detections constituted the first encounters with polio in the United States and United Kingdom for a generation - for both public health agencies and publics alike.
View Article and Find Full Text PDFIntroduction: The introduction of a national evaluation of newborn screening for Severe Combined Immunodeficiency (SCID) in England triggered a change to the selective Bacillus Calmette-Guerin (BCG) vaccination programme delivery pathway, as this live attenuated vaccine is contraindicated in infants with SCID. The neonatal BCG vaccination programme is a targeted programme for infants at increased risk of tuberculosis and used to be offered shortly after birth. Since September 2021 the BCG vaccine is given to eligible infants within 28 days of birth, when the SCID screening outcome is available.
View Article and Find Full Text PDF